Human Perception of Odors and Odor Blockers
Launched by TIM MCCLINTOCK · Dec 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether certain odor blockers can help people quit smoking by making the smell of cigarette smoke less intense and less appealing. The main question is whether these blockers can reduce the urge to smoke by changing how strongly people perceive the odors associated with smoking. If you’re a smoker and are interested in finding a new way to help you quit, this might be a good opportunity for you.
Participants will take part in sessions where they will smell up to 20 different odors and then share how pleasant they find those smells and whether they feel a desire to smoke afterward. To join the study, you need to be a smoker. Unfortunately, if you don't smoke or if you have trouble smelling or tasting, you won't be eligible to participate. This trial is currently recruiting participants aged between 18 to 75, and both men and women can join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Smoker
- Exclusion Criteria:
- • Non Smoker
- • Self reported inability to smell or taste
About Tim Mcclintock
Tim McClintock is a dedicated clinical trial sponsor with extensive experience in the design and management of innovative research studies. Committed to advancing medical knowledge and improving patient outcomes, McClintock leverages a collaborative approach, working closely with healthcare professionals, regulatory bodies, and research organizations. His focus spans various therapeutic areas, emphasizing rigorous adherence to ethical standards and regulatory compliance. By fostering a culture of transparency and accountability, Tim McClintock aims to deliver high-quality clinical trials that contribute to the development of effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Trial Officials
Timothy McClintock, PhD
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported